Showing results (161-170 of 183) with videos related to

Sort By:
Pageof 19
British Journal of Cancer|October 13, 2006
Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapiesS Leyvraz, R Herrmann, L Guillou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2000
The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK)M Ghielmini, S F Schmitz, K Bürki, et al.
Lung Cancer (Amsterdam, Netherlands)|September 7, 2016
Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based studyP Neumair, L Joos, R Warschkow, et al.
British Journal of Cancer|February 4, 2010
Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic-pharmacodynamic analysis from the IELSG no. 20 trialM Joerger, A D R Huitema, S Krähenbühl, et al.
Journal of Internal Medicine|May 19, 2004
Readmissions and adverse drug reactions in internal medicine: the economic impactH Dormann, A Neubert, M Criegee-Rieck, et al.
Frontiers in Psychiatry|January 19, 2026
Capacity to give informed consent in patients with severe mental disorder in different treatment settingsMounira Jabat, Mona Redlich Bossy, Nikolaus Bausch Becker, et al.
The Annals of Thoracic Surgery|May 22, 1998
Isolated lung perfusion: single-pass system versus recirculating blood perfusion in pigsM Furrer, D Lardinois, W Thormann, et al.
Frontiers in Psychiatry|May 16, 2022
Relationship Between Time of Admission, Help-Seeking Behavior, and Psychiatric Outcomes: "From Dusk Till Dawn"Marius Knorr, Andreas B Hofmann, Dimitrina Miteva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 1998
Reduced dose of subcutaneous cladribine induces identical response rates but decreased toxicity in pretreated chronic lymphocytic leukaemia. Swiss Group for Clinical Cancer Research (SAKK)D C Betticher, D Ratschiller, S F Hsu Schmitz, et al.
British Journal of Cancer|January 10, 2008
Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover studyF Strasser, T A Lutz, M T Maeder, et al.
Pageof 19